×
返回 Agenda
Session Chair(s)
Barbara J Van Zwieten-Boot, PHD, FACP
Chairperson, Efficacy Working Party, CHMP, EMEA, EU
Medicines Evaluation Board, Netherlands
Speaker(s)
Biomarker Qualification Procedure
Violeta Stoyanova-Beninska, MD, PHD, MPH
Medicines Evaluation Board, Netherlands
Chair COMP EMA, Chair Scientific and Regulatory Advice MEB
Challenges in the Revised Guideline for Depression
Karl Broich, DrMed
Federal Institute for Drugs and Medical Devices (BfArM), Germany
President
Changes in the Field of Multiple Sclerosis
Andre J.A. Elferink, MD, PHD, MSC
CBG-MEB, Netherlands
Head Clinical Assessors